We are monitoring the impact of COVID-19 on Veterinary/Animal Vaccines Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 58
Share on
Share on

Global Veterinary/Animal Vaccines Market Size, Share, Trends and Growth Analysis Report – Segmented By Product Type (Livestock Vaccines and Companion Vaccines), By Production Technologies (live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Subunit Vaccines, DNA Vaccines and Conjugate Vaccines) and By Region - Industry Forecast | 2020 to 2025

Pulished: February, 2020
ID: 58
Pages: 177

Veterinary/Animal Vaccines Market Size (2020 to 2025)

As per our report, the global veterinary/animal vaccines market is poised to grow USD 8.46 Billion by 2025 from USD 6.47 Billion in 2020. This market is predicted to showcase a CAGR of 5.5% from 2020 to 2025. Veterinary Vaccines Market has seen significant growth over the past few years, due to fear of imminent epidemics that have led to substantial losses, particularly in the poultry segment.

Veterinary vaccines are given regularly for both pet and poultry animals to prevent diseases. These vaccines are manufactured following different types of bacteria affecting varied animals. In traditional days, these vaccines are considered as the most cost-effective procedure for treating infectious diseases in animals. Veterinary vaccines are an essential thing in protecting animal health.

From traditional days, veterinary vaccines are effective procedures for preventing various diseases in animals. It also helps in preventing the transmission of diseases from animals to humans. Veterinary vaccines improve the health of the animals cost-effectively. These vaccines aim to increase the production rate of poultry products by improving the health of the livestock.

MARKET DRIVERS

Growing prevalence of livestock and zoonotic diseases and the advancements in animal vaccines are majorly driving the veterinary vaccines market.

Veterinary vaccines manufacturers pay attention to reduce the risk of various diseases in animals, which demands proper vaccination and driving growth for the market. Improving quality and effectiveness in the production of poultry products, increasing care for pet animals, and the rising consumption rate of meat and poultry products such as egg and others are further accelerating the demand for the animal vaccines market.

According to a Food and Agriculture organization study, more animal diseases can be easily transmissible to the humans where pharmaceutical companies have to be focused on the manufacturing of various vaccines accordingly, which is estimated to expand the growth of the veterinary vaccines market.

Furthermore, factors like increasing disposable income in urban areas, focus on manufacturing novel vaccines to meet the requirement of animal needs in the medical sector are bolstering market growth. Growing prevalence for the DNA vaccines and recombinants vaccines are also playing an essential role in providing growth scope to the global veterinary vaccines market.

MARKET RESTRAINTS

However, rising maintenance costs for the storage of vaccines, increasing adoption of a vegetarian diet in major economies owing to the increased risk of obesity and other chronic diseases are necessary restraints are expected to restrict the growth of the global veterinary vaccines market.

The fluctuations in the prices of the end products are slowly hampering the growth of this market. Lack of skilled persons in manufacturing and stringent rules and regulations by the government for the approval of new vaccines is limiting the demand of the market. Rise in the complications of specific vaccines in real-time due to lack of knowledge over the dosage level is remained a challenging factor for the market growth.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Type, Production Technologies and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global veterinary vaccines market has been segmented based on the type, production technologies, and region.

Veterinary Vaccines Market - By Type

  • Livestock Vaccines
    • Bovine
    • Porcine
    • Ovine
    • Poultry
    • Equine  
  • Companion Vaccines
    • Feline Vaccines
    • Canine Vaccines

Based on the type, the Livestock vaccine segment is leading the market with the highest shares. Increasing the livestock population is majorly attributing the growth to this segment. Growing concern towards animal healthcare, rise in the demand to prevent the spread of diseases from animals to humans is other factors helping this segment to shine. Among different types of livestock vaccines, the porcine segment is witnessed in having the highest shares of the market. Increasing incidences of zoonotic diseases are ascribed to outshine the demand of the market. Rise in the campaigns to spread awareness in rural areas over the benefits of vaccines is gearing up the need of the market.

Among companion vaccines, the canine vaccines segment accounted for a slightly larger share (in terms of revenue) than the feline vaccines segment, due to higher average cost allied with canine vaccination.

Veterinary Vaccines Market - By Production Technologies

  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines
  • Toxoid Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Conjugate Vaccines

Based on production technologies, Live attenuated vaccines production technology is having the highest growth rate from the past few years and is to continue the same growth in the coming years. The introduction of various products with advanced technologies, increasing awareness towards manufacturing effective vaccines inappropriate with the diseases is spurring the growth rate of the market. Rise in the investments on veterinary hospitals by both private and public organizations is further gearing up the demand of the segment.

Veterinary Vaccines Market - By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

The North American region is leading the veterinary vaccine market in terms of consumption, followed by Europe. These two regions together account for more than 70% of the global veterinary vaccine market revenue. In Europe, Increasing incidences of zoonotic diseases and demand to prevent and cure of these diseases with certain medications is expanding the growth rate of the veterinary vaccines market. Stringent rules and regulations to promote effective treatment procedures in the hospitals are leveraging the growth of the market in this region.

Europe is expected to grow at a healthy CAGR due to the quick adoption of the latest technologies and the launch of various quality products at a low cost. Besides, increasing capita income in developed and developing countries is likely to outshine the growth of the market to the extent.

Asia pacific is positioned next to North America in leading dominant shares of the market with the increased priority to improve the quality of poultry products is escalating the growth of the market. Also, a rise in the awareness programs through campaigns and digital advertisements are elevating the demand of the market.

The Middle East and Africa are having a slow growth rate from recent years, and it is expected to have a slight inclination in the growth rate in the coming years.

TOP COMPANIES IN THE MARKET

Notable companies in the global veterinary/animal vaccines market profiled in the report are Bayer HealthCare AG, Sanofi Animal Health, Inc., Heska Corporation, Indian Immunologicals Ltd., Biogenesis Bago SA, Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Health, Inc., Merck & Co. Inc. and Protein Sciences.

RECENT MARKET DEVELOPMENTS

Acquisition – In 2019

Zoetis Company has completed the acquisition of ZNLabs, and Phoenix Lab, to enhance its diagnostics and laboratory services for veterinarian professionals and customers in the United States.

Product Launch – In 2019

Boehringer Ingelheim Company has recently developed a swine vaccine called ingel vac PRRS MLV in its manufacturing plant located in China, and the company has started supplying the vaccines to china's market officially from Jan 2019.

Acquisition – In 2017

Merck Animal Health acquired Valee S.A in 2017; this deal is likely to expand the distribution network of Merck animal health products in Brazil.

Acquisition – In 2017

Elanco Animal Health Company has expanded its vaccine product portfolio by completing the acquisition of Boehringer Ingelheim Vetmedica’s U.S. Feline, Canine, and Rabies Vaccines Portfolio.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Type
      1. Livestock Vaccines
        1. Bovine
        2. Porcine
        3. Ovine
        4. Poultry
        5. Equine
        6. Y-o-Y Growth Analysis, By Livestock Vaccines Type
        7. Market Attractiveness Analysis, By Livestock Vaccines Type
        8. Market Share Analysis, By Livestock Vaccines Type
      2. Companion Vaccines
        1. Feline Vaccines
        2. Canine Vaccines
        3. Y-o-Y Growth Analysis, By Companion Vaccines Type
        4. Market Attractiveness Analysis, By Companion Vaccines Type
        5. Market Share Analysis, By Companion Vaccines Type
    2. By Production Technologies
      1. Live Attenuated Vaccines
      2. Inactivated Vaccines
      3. Recombinant Vaccines
      4. Toxoid Vaccines
      5. Subunit Vaccines
      6. DNA Vaccines
      7. Conjugate Vaccines
      8. Y-o-Y Growth Analysis, By Production Technologies Type
      9. Market Attractiveness Analysis, By Production Technologies Type
      10.  Market Share Analysis, By Production Technologies Type
  6. Geographical Analysis
    1. North America
      1. Introduction
      2. US
      3. Canada
      4. Mexico
      5. Rest of North America
    2. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
      7. Russia
      8. Sweden
      9. Denmark
      10. Switzerland
      11. Netherlands
      12. Turkey
      13. Czech Republic
      14. Rest of Europe
    3. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
      7. New Zealand
      8. Thailand
      9. Malaysia
      10. Vietnam
      11. Philippines
      12. Indonesia
      13. Singapore
      14. Rest of APAC
    4. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Chile
      5. Rest of Latin America
    5. Middle East & Africa
      1. Introduction
      2. KSA
      3. UAE
      4. Israel
      5. Rest of GCC countries
      6. South Africa
      7. Ethiopia
      8. Kenya
      9. Egypt
      10. Sudan
      11. Rest of MEA
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Bayer HealthCare AG
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Bioniche Animal Health Canada
    3. Sanofi Animal Health, Inc.
    4. Biogenesis Bago SA
    5. Heska Corporation
    6. Indian Immunologicals Ltd.
    7. Boehringer Ingelheim GmbH
    8. Zoetis
    9. Novartis Animal Health, Inc.
    10. Merck & Co. Inc
    11. Protein Sciences
  9.  Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Type and Technology along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Global Veterinary Vaccines Market By Region, From 2020 to 2025 (USD Million)
  2. Global Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  3. Global Livestock vaccines Market By Region, From 2020 to 2025 (USD Million)
  4. Global Companion vaccines Market By Region, From 2020 to 2025 (USD Million)
  5. Global Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  6. Global Live attenuated vaccines Market By Region, From 2020 to 2025 (USD Million)
  7. Global Inactivated vaccines Market By Region, From 2020 to 2025 (USD Million)
  8. Global Recombinant vaccines Market By Region, From 2020 to 2025 (USD Million)
  9. Global Toxoid vaccines Market By Region, From 2020 to 2025 (USD Million)
  10. Global Subunit vaccines Market By Region, From 2020 to 2025 (USD Million)
  11. Global DNA vaccines Market By Region, From 2020 to 2025 (USD Million)
  12. Global Conjugate vaccines Market By Region, From 2020 to 2025 (USD Million)
  13. Global Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  14. Global Bovine Market By Region, From 2020 to 2025 (USD Million)
  15. Global porcine Market By Region, From 2020 to 2025 (USD Million)
  16. Global Ovine Market By Region, From 2020 to 2025 (USD Million)
  17. Global Poultry Market By Region, From 2020 to 2025 (USD Million)
  18. Global Equine Market By Region, From 2020 to 2025 (USD Million)
  19. Global Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  20. Global canine Market By Region, From 2020 to 2025 (USD Million)
  21. Global feline Market By Region, From 2020 to 2025 (USD Million)
  22. North America Veterinary Vaccines Market By Region, From 2020 to 2025 (USD Million)
  23. North America Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  24. North America Livestock vaccines Market By Region, From 2020 to 2025 (USD Million)
  25. North America Companion vaccines Market By Region, From 2020 to 2025 (USD Million)
  26. North America Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  27. North America Live attenuated vaccines Market By Region, From 2020 to 2025 (USD Million)
  28. North America Inactivated vaccines Market By Region, From 2020 to 2025 (USD Million)
  29. North America Recombinant vaccines Market By Region, From 2020 to 2025 (USD Million)
  30. North America Toxoid vaccines Market By Region, From 2020 to 2025 (USD Million)
  31. North America Subunit vaccines Market By Region, From 2020 to 2025 (USD Million)
  32. North America DNA vaccines Market By Region, From 2020 to 2025 (USD Million)
  33. North America Conjugate vaccines Market By Region, From 2020 to 2025 (USD Million)
  34. North America Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  35. North America Bovine Market By Region, From 2020 to 2025 (USD Million)
  36. North America porcine Market By Region, From 2020 to 2025 (USD Million)
  37. North America Ovine Market By Region, From 2020 to 2025 (USD Million)
  38. North America Poultry Market By Region, From 2020 to 2025 (USD Million)
  39. North America Equine Market By Region, From 2020 to 2025 (USD Million)
  40. North America Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  41. North America canine Market By Region, From 2020 to 2025 (USD Million)
  42. North America feline Market By Region, From 2020 to 2025 (USD Million)
  43. United States Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  44. United States Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  45. Canada Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  46. Canada Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  47. United States Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  48. Canada Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  49. United States Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  50. Canada Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  51. Europe Veterinary Vaccines Market By Region, From 2020 to 2025 (USD Million)
  52. Europe Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  53. Europe Livestock vaccines Market By Region, From 2020 to 2025 (USD Million)
  54. Europe Companion vaccines Market By Region, From 2020 to 2025 (USD Million)
  55. Europe Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  56. Europe Live attenuated vaccines Market By Region, From 2020 to 2025 (USD Million)
  57. Europe Inactivated vaccines Market By Region, From 2020 to 2025 (USD Million)
  58. Europe Recombinant vaccines Market By Region, From 2020 to 2025 (USD Million)
  59. Europe Toxoid vaccines Market By Region, From 2020 to 2025 (USD Million)
  60. Europe Subunit vaccines Market By Region, From 2020 to 2025 (USD Million)
  61. Europe DNA vaccines Market By Region, From 2020 to 2025 (USD Million)
  62. Europe Conjugate vaccines Market By Region, From 2020 to 2025 (USD Million)
  63. Europe Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  64. Europe Bovine Market By Region, From 2020 to 2025 (USD Million)
  65. Europe porcine Market By Region, From 2020 to 2025 (USD Million)
  66. Europe Ovine Market By Region, From 2020 to 2025 (USD Million)
  67. Europe Poultry Market By Region, From 2020 to 2025 (USD Million)
  68. Europe Equine Market By Region, From 2020 to 2025 (USD Million)
  69. Europe Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  70. Europe canine Market By Region, From 2020 to 2025 (USD Million)
  71. Europe feline Market By Region, From 2020 to 2025 (USD Million)
  72. U.K. Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  73. U.K. Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  74. Germany Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  75. Germany Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  76. France Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  77. France Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  78. Italy Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  79. Italy Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  80. Spain Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  81. Spain Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  82. U.K. Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  83. Germany Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  84. France Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  85. Italy Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  86. Spain Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  87. U.K. Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  88. Germany Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  89. France Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  90. Italy Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  91. Spain Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  92. Asia-Pacific Veterinary Vaccines Market By Region, From 2020 to 2025 (USD Million)
  93. Asia-Pacific Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  94. Asia-Pacific Livestock vaccines Market By Region, From 2020 to 2025 (USD Million)
  95. Asia-Pacific Companion vaccines Market By Region, From 2020 to 2025 (USD Million)
  96. Asia-Pacific Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  97. Asia-Pacific Live attenuated vaccines Market By Region, From 2020 to 2025 (USD Million)
  98. Asia-Pacific Inactivated vaccines Market By Region, From 2020 to 2025 (USD Million)
  99. Asia-Pacific Recombinant vaccines Market By Region, From 2020 to 2025 (USD Million)
  100. Asia-Pacific Toxoid vaccines Market By Region, From 2020 to 2025 (USD Million)
  101. Asia-Pacific Subunit vaccines Market By Region, From 2020 to 2025 (USD Million)
  102. Asia-Pacific DNA vaccines Market By Region, From 2020 to 2025 (USD Million)
  103. Asia-Pacific Conjugate vaccines Market By Region, From 2020 to 2025 (USD Million)
  104. Asia-Pacific Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  105. Asia-Pacific Bovine Market By Region, From 2020 to 2025 (USD Million)
  106. Asia-Pacific porcine Market By Region, From 2020 to 2025 (USD Million)
  107. Asia-Pacific Ovine Market By Region, From 2020 to 2025 (USD Million)
  108. Asia-Pacific Poultry Market By Region, From 2020 to 2025 (USD Million)
  109. Asia-Pacific Equine Market By Region, From 2020 to 2025 (USD Million)
  110. Asia-Pacific Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  111. Asia-Pacific canine Market By Region, From 2020 to 2025 (USD Million)
  112. Asia-Pacific feline Market By Region, From 2020 to 2025 (USD Million)
  113. China Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  114. China Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  115. India Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  116. India Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  117. Japan Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  118. Japan Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  119. South Korea Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  120. South Korea Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  121. China Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  122. India Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  123. Japan Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  124. South Korea Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  125. China Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  126. India Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  127. Japan Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  128. South Korea Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  129. Latin America Veterinary Vaccines Market By Region, From 2020 to 2025 (USD Million)
  130. Latin America Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  131. Latin America Livestock vaccines Market By Region, From 2020 to 2025 (USD Million)
  132. Latin America Companion vaccines Market By Region, From 2020 to 2025 (USD Million)
  133. Latin America Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  134. Latin America Live attenuated vaccines Market By Region, From 2020 to 2025 (USD Million)
  135. Latin America Inactivated vaccines Market By Region, From 2020 to 2025 (USD Million)
  136. Latin America Recombinant vaccines Market By Region, From 2020 to 2025 (USD Million)
  137. Latin America Toxoid vaccines Market By Region, From 2020 to 2025 (USD Million)
  138. Latin America Subunit vaccines Market By Region, From 2020 to 2025 (USD Million)
  139. Latin America DNA vaccines Market By Region, From 2020 to 2025 (USD Million)
  140. Latin America Conjugate vaccines Market By Region, From 2020 to 2025 (USD Million)
  141. Latin America Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  142. Latin America Bovine Market By Region, From 2020 to 2025 (USD Million)
  143. Latin America porcine Market By Region, From 2020 to 2025 (USD Million)
  144. Latin America Ovine Market By Region, From 2020 to 2025 (USD Million)
  145. Latin America Poultry Market By Region, From 2020 to 2025 (USD Million)
  146. Latin America Equine Market By Region, From 2020 to 2025 (USD Million)
  147. Latin America Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  148. Latin America canine Market By Region, From 2020 to 2025 (USD Million)
  149. Latin America feline Market By Region, From 2020 to 2025 (USD Million)
  150. Brazil Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  151. Brazil Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  152. Argentina Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  153. Argentina Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  154. Mexico Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  155. Mexico Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  156. Brazil Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  157. Argentina Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  158. Mexico Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  159. Brazil Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  160. Argentina Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  161. Mexico Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  162. Middle East & Africa Veterinary Vaccines Market By Region, From 2020 to 2025 (USD Million)
  163. Middle East & Africa Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  164. Middle East & Africa Livestock vaccines Market By Region, From 2020 to 2025 (USD Million)
  165. Middle East & Africa Companion vaccines Market By Region, From 2020 to 2025 (USD Million)
  166. Middle East & Africa Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  167. Middle East & Africa Live attenuated vaccines Market By Region, From 2020 to 2025 (USD Million)
  168. Middle East & Africa Inactivated vaccines Market By Region, From 2020 to 2025 (USD Million)
  169. Middle East & Africa Recombinant vaccines Market By Region, From 2020 to 2025 (USD Million)
  170. Middle East & Africa Toxoid vaccines Market By Region, From 2020 to 2025 (USD Million)
  171. Middle East & Africa Subunit vaccines Market By Region, From 2020 to 2025 (USD Million)
  172. Middle East & Africa DNA vaccines Market By Region, From 2020 to 2025 (USD Million)
  173. Middle East & Africa Conjugate vaccines Market By Region, From 2020 to 2025 (USD Million)
  174. Middle East & Africa Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  175. Middle East & Africa Bovine Market By Region, From 2020 to 2025 (USD Million)
  176. Middle East & Africa porcine Market By Region, From 2020 to 2025 (USD Million)
  177. Middle East & Africa Ovine Market By Region, From 2020 to 2025 (USD Million)
  178. Middle East & Africa Poultry Market By Region, From 2020 to 2025 (USD Million)
  179. Middle East & Africa Equine Market By Region, From 2020 to 2025 (USD Million)
  180. Middle East & Africa Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  181. Middle East & Africa canine Market By Region, From 2020 to 2025 (USD Million)
  182. Middle East & Africa feline Market By Region, From 2020 to 2025 (USD Million)
  183. Middle East Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  184. Middle East Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  185. Africa Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  186. Africa Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  187. Middle East Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  188. Africa Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  189. Middle East Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  190. Africa Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample